What's in Bionorica SE's pipeline?

Bionorica SE has 8 drugs in our index: 0 marketed, 0 filed, 6 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Bionorica SE's portfolio?

Top competitors by shared drug class: Hospital Vall d'Hebron, Marjan Industria e Comercio ltda, Phytopharm Consulting Brazil.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/bionorica-se.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Bionorica SE — Portfolio Competitive Intelligence Brief

Bionorica SE pipeline: 0 marketed, 0 filed, 6 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 6 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Sinupret extract coated tablets	Sinupret extract coated tablets	phase 3	Herbal combination / phytotherapeutic agent	Otolaryngology / Respiratory
Canephron® N	Canephron® N	phase 3	Herbal combination / Phytopharmaceutical	Urology / Nephrology
BNO 1016	BNO 1016	phase 3	Herbal combination / Phytotherapeutic agent	Respiratory / Pulmonology
BX-1	BX-1	phase 3	Herbal/Phytopharmaceutical	Respiratory/Immunology
VAC BNO 1095 film coated tablets	VAC BNO 1095 film coated tablets	phase 3	Herbal medicinal product	Immunology / Respiratory / Inflammation
Placebo coated tablets	Placebo coated tablets	phase 3

Therapeutic area mix

Immunology / Respiratory / Inflammation · 1
Otolaryngology / Respiratory · 1
Respiratory / Pulmonology · 1
Respiratory/Immunology · 1
Urology / Nephrology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Hospital Vall d'Hebron · 1 shared drug class
Marjan Industria e Comercio ltda · 1 shared drug class
Phytopharm Consulting Brazil · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Bionorica SE:

Cite this brief

Drug Landscape (2026). Bionorica SE — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bionorica-se. Accessed 2026-05-16.